New processors installed in CUIMC’s High Performance Computing Cluster are designed to give a major boost to AI in biomedical research and analyze increasingly dense and complex biomedical data.
Older adults in England have experienced significant improvements in health compared to previous generations, researchers at Columbia's Robert N. Butler Aging Center have found.
With funding from ARPA-H, a team led by Columbia researchers plans to build an implantable device—filled with engineered cells—that regulates appetite, digestion, and blood sugar.
Ten years ago, a Columbia postdoc identified a simple nutrient that can alleviate Parkinson’s disease symptoms in mice by rewiring the brain. It’s finally being put to the test in people.
The new report addresses the responsible use of race and ethnicity in biomedical research and is a call to action for biomedical research to rethink how it uses race and ethnicity.
Timely discussions about the goals of care ensure that nursing home residents receive care that aligns with their wishes but are less likely in homes with a higher percentage of Black residents.
Columbia scientists investigating the roots of social wiring in the brain discussed their work at a symposium designed to explore diverse perspectives on this complex topic.
Researchers and clinicians at Columbia University Vagelos College of Physicians and Surgeons are studying how artificial intelligence can translate to better patient care.
Columbia’s Dian Yang is placing CRISPR-based molecular recorders into cancer cells to eavesdrop on cancer evolution and pinpoint when and how cells metastasize.
With the opening of the BRIDGE facility, Columbia will be able to house up to 12 million patient samples connected with health data to accelerate medical discovery.